NCT05469490 2022-09-30Safety of Navoximod and NLG802 With Stereotactic Body Radiotherapy (SBRT) Treatment of Advanced Solid TumorsUniversity of PittsburghPhase 1 Withdrawn
NCT02471846 2019-10-22A Study of GDC-0919 and Atezolizumab Combination Treatment in Participants With Locally Advanced or Metastatic Solid TumorsGenentech, Inc.Phase 1 Completed158 enrolled
NCT02048709 2017-02-06Indoleamine 2,3-Dioxygenase (IDO) Inhibitor in Advanced Solid TumorsGenentech, Inc.Phase 1 Completed22 enrolled